These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6985282)

  • 1. [The TAO-methylprednisolone combination in chronic obstructive bronchopneumopathy. Clinical, metabolic and hormonal aspects].
    Logroscino CD; Maringelli D; Losito G; Tota N
    G Ital Chemioter; 1982; 29(2):133-8. PubMed ID: 6985282
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.
    Harris R; German D
    Ann Allergy; 1989 Aug; 63(2):110-1. PubMed ID: 2788376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with a combination therapy of methylprednisolone and troleandomycin in severe bronchial asthma requiring high-dose corticoids].
    Menz G; Rothe T; Schmitt M; Schmitz M; Hauser F; Haack D; Virchow C
    Pneumologie; 1990 Feb; 44 Suppl 1():238-40. PubMed ID: 2367377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troleandomycin and methylprednisolone for treatment of the hypereosinophilic syndrome.
    Edwards D; Wald JA; Dobozin BS; Kirkpatrick CH
    N Engl J Med; 1987 Aug; 317(9):573-4. PubMed ID: 3497348
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of TAO without methylprednisolone in the treatment of severe asthma.
    Rosenberg SM; Gerhard H; Grunstein MM; Schramm CM
    Chest; 1991 Sep; 100(3):849-50. PubMed ID: 1889284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose- and time-related effect of troleandomycin on methylprednisolone elimination.
    Szefler SJ; Brenner M; Jusko WJ; Spector SL; Flesher KA; Ellis EF
    Clin Pharmacol Ther; 1982 Aug; 32(2):166-71. PubMed ID: 6980076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled use of glucocorticoids in asthma. Monitoring by peak flow measurements--new therapies].
    Stemmer B
    Fortschr Med; 1988 Sep; 106(27):67-8. PubMed ID: 3263305
    [No Abstract]   [Full Text] [Related]  

  • 8. [Corticoids and selective beta 2-agonists: spirometric synergism and oxymetric antagonism].
    Díez Jarilla JL; Cruz Hernández JJ; del Pino Montes J; Sánchez Gascón F; de Portugal Alvarez J
    Rev Clin Esp; 1982 Oct; 167(2):113-6. PubMed ID: 7178594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of a salbutamol-beclomethasone dipropionate combination in the treatment of chronic obstructive bronchopneumopathy].
    Greco N; Tosto L
    Clin Ter; 1984 Sep; 110(5):445-53. PubMed ID: 6238759
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of troleandomycin and methylprednisolone alone and in combination on bronchial sensitivity to methacholine.
    Andrade WP; Renard RL; Nelson HS
    Ann Allergy; 1983 Nov; 51(5):515-7. PubMed ID: 6356997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pluridirectional treatment of chronic, obstructive bronchopneumopathy with rectal administration of a new drug combination].
    Nappi L; Taglialatela G; Verde F
    Clin Ter; 1972 Dec; 63(6):577-86. PubMed ID: 4570863
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylprednisolone and troleandomycin in treatment of steroid-dependent asthmatic children.
    Eitches RW; Rachelefsky GS; Katz RM; Mendoza GR; Siegel SC
    Am J Dis Child; 1985 Mar; 139(3):264-8. PubMed ID: 3872062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and complications of troleandomycin (TAO) in young children with steroid-dependent asthma.
    Flotte TR; Loughlin GM
    Pediatr Pulmonol; 1991; 10(3):178-82. PubMed ID: 1852515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.
    Wald JA; Friedman BF; Farr RS
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):36-43. PubMed ID: 3487564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strongyloidiasis and glucocorticoids: case report.
    Kebede D
    Va Med; 1986 Feb; 113(2):104-5. PubMed ID: 3953139
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy.
    Szefler SJ; Ellis EF; Brenner M; Rose JQ; Spector SL; Yurchak AM; Andrews F; Jusko WJ
    J Allergy Clin Immunol; 1982 May; 69(5):455-60. PubMed ID: 6978898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of troleandomycin on methylprednisolone elimination.
    Szefler SJ; Rose JQ; Ellis EF; Spector SL; Green AW; Jusko WJ
    J Allergy Clin Immunol; 1980 Dec; 66(6):447-51. PubMed ID: 6968763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug treatment of chronic obstructive pulmonary disease].
    van Herwaarden CL; Dekhuijzen PN; van Schayck CP; van Weel C; Molema J
    Ned Tijdschr Geneeskd; 1996 Apr; 140(14):761-5. PubMed ID: 8668261
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma.
    Zeiger RS; Schatz M; Sperling W; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 1980 Dec; 66(6):438-46. PubMed ID: 6968762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.
    Ebling WF; Rich SA; Szefler SJ; Jusko WJ
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):50-7. PubMed ID: 3497038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.